RhumbLine Advisers’s Picard Medical PMI Stock Holding History

RhumbLine Advisers’s Portfolio PMI Stock Details PMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-171	Closed	-$8.9K	–	4293
2026 Q1	$8.9K	Buy	171 +82	+92%	+$5.94K	﹤0.01%	3820
2025 Q4	$7.83K	Buy	+89	New	+$20.9K	﹤0.01%	3884

Other funds holding PMI

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

RhumbLine Advisers's PMI Position: Q2 2026 in Review

RhumbLine Advisers sold out of Picard Medical (PMI) in Q2 2026, closing a stake of 171 shares — an estimated $8.9K sold.

RhumbLine Advisers first reported a position in PMI in Q4 2025 and held it in 2 quarters. The position peaked at $8.9K in Q1 2026. 41 funds tracked by Wall St. Rank hold PMI as of Q2 2026.

RhumbLine Advisers reported no remaining Picard Medical position as of Q2 2026 after selling out during the quarter.
RhumbLine Advisers sold 171 Picard Medical shares in Q2 2026, an estimated $8.9K.
RhumbLine Advisers first reported a position in Picard Medical in Q4 2025 and held it in 2 quarters.
RhumbLine Advisers's Picard Medical position peaked at $8.9K in Q1 2026.
41 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.